PRESS RELEASE published on 04/09/2025 at 15:31, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc The Vanguard Group, Inc. discloses a 5.58% stake in Primary Health Properties plc as of 08 April 2025, along with dealings in relevant securities Relevant Securities Vanguard Group Stake Disclosure Dealings Primary Health Properties
BRIEF published on 04/09/2025 at 15:31, 1 year 5 months ago Vanguard Group Discloses Position in Dowlais Group plc Disclosure Takeover Code Vanguard Stockholding Dowlais Group
PRESS RELEASE published on 04/09/2025 at 15:30, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc The Vanguard Group, Inc. discloses 3.94% ownership in TI Fluid Systems plc in Form 8.3 filing on 09-Apr-2025 The Vanguard Group Ownership Disclosure Financial Disclosure Form 8.3 Filing TI Fluid Systems Plc
BRIEF published on 04/09/2025 at 15:30, 1 year 5 months ago The Vanguard Group Discloses Position in Bakkavor Group Form 8.3 Takeover Code Vanguard Group Bakkavor Group Security Interests
BRIEF published on 04/09/2025 at 15:29, 1 year 5 months ago The Vanguard Group Discloses Position in PRS REIT plc Securities Disclosure The Vanguard Group Takeover Code PRS REIT Plc
PRESS RELEASE published on 04/09/2025 at 15:29, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Assura plc The Vanguard Group, Inc. discloses a 5.60% interest in Assura plc's 10p ordinary securities in compliance with Rule 8.3 of the Takeover Code The Vanguard Group Rule 8.3 Takeover Code 10p Ordinary Securities Assura Plc
PRESS RELEASE published on 04/09/2025 at 15:28, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Aviva plc The Vanguard Group, Inc. discloses a 5.12% ownership stake in Aviva plc through Form 8.3 filing. Additional disclosure on Direct Line Insurance Group plc included Form 8.3 Vanguard Group Inc. Ownership Stake Direct Line Insurance Aviva Plc
BRIEF published on 04/09/2025 at 15:28, 1 year 5 months ago The Vanguard Group Discloses Position in Wood Group (John) plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Wood Group
PRESS RELEASE published on 04/09/2025 at 15:27, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc The Vanguard Group, Inc. discloses a 1.00% interest in Life Science REIT plc per Form 8.3 filing. Transactions include sale of 1p ordinary shares at 0.42 GBP per unit Form 8.3 Disclosure Vanguard Group Inc. Share Sale Life Science REIT Plc
BRIEF published on 04/09/2025 at 15:27, 1 year 5 months ago The Vanguard Group Releases Form 8.3 for LondonMetric Property plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group LondonMetric Property
Published on 09/12/2026 at 02:35, 18 hours 35 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 22 hours 10 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 23 hours 5 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 23 hours 45 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 4 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 3 hours 19 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 13 hours 39 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 22 hours 54 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 22 hours 59 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 1 hour ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 14 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 2 days 1 hour ago Availability of the 2026 Interim Financial Report
